Abstract |
|
Authors | Melita Kenealy, Mark Hertzberg, Warwick Benson, Kerry Taylor, Ilona Cunningham, Will Stevenson, Devendra Hiwase, Richard Eek, Daniela Zantomio, Steve Jong, Meaghan Wall, Piers Blombery, Tracey Gerber, Marlyse Debrincat, Diana Zannino, John F Seymour |
Journal | Haematologica
(Haematologica)
Vol. 104
Issue 4
Pg. 700-709
(04 2019)
ISSN: 1592-8721 [Electronic] Italy |
PMID | 30545923
(Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright© 2019 Ferrata Storti Foundation. |
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Azacitidine
(administration & dosage, adverse effects)
- Blast Crisis
(drug therapy, mortality)
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Lenalidomide
(administration & dosage, adverse effects)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
(drug therapy, mortality)
- Leukemia, Myeloid, Acute
(drug therapy, mortality)
- Male
- Middle Aged
- Myelodysplastic Syndromes
(drug therapy, mortality)
- Risk Factors
- Survival Rate
|